Total Payments
$1,502
2024 Payments
$20.33
Companies
19
Transactions
43
Medicare Patients
1,671
Medicare Billing
$198,209
Payment Breakdown by Category
Food & Beverage$1,478 (98.4%)
Other$23.54 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,478 | 42 | 98.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23.54 | 1 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $180.29 | 9 | $0 (2024) |
| IMPEL PHARMACEUTICALS INC. | $160.08 | 4 | $0 (2023) |
| Celgene Corporation | $148.40 | 2 | $0 (2022) |
| Cardiovascular Systems Inc. | $141.78 | 1 | $0 (2017) |
| Boston Scientific Corporation | $138.26 | 2 | $0 (2020) |
| ABBVIE INC. | $125.44 | 5 | $0 (2023) |
| Harmony Biosciences LLC | $120.01 | 1 | $0 (2023) |
| ARGENX US, INC. | $110.00 | 1 | $0 (2023) |
| Alnylam Pharmaceuticals Inc. | $80.64 | 1 | $0 (2022) |
| EMD Serono, Inc. | $62.56 | 3 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $20.33 | 1 | Novartis Pharmaceuticals Corporation ($20.33) |
| 2023 | $523.97 | 11 | IMPEL PHARMACEUTICALS INC. ($160.08) |
| 2022 | $173.24 | 6 | Alnylam Pharmaceuticals Inc. ($80.64) |
| 2021 | $298.96 | 10 | Celgene Corporation ($124.91) |
| 2020 | $205.57 | 6 | Boston Scientific Corporation ($122.63) |
| 2019 | $78.85 | 4 | Acorda Therapeutics, Inc ($23.54) |
| 2018 | $26.09 | 2 | Biogen, Inc. ($26.09) |
| 2017 | $174.96 | 3 | Cardiovascular Systems Inc. ($141.78) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/07/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.33 | General |
| Category: Neurology | ||||||
| 09/19/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $20.69 | General |
| Category: Neurology | ||||||
| 08/07/2023 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $34.62 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/17/2023 | ARGENX US, INC. | VYVGART (Drug) | Food and Beverage | In-kind items and services | $110.00 | General |
| Category: Immunology | ||||||
| 07/17/2023 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $27.45 | General |
| Category: Neurology | ||||||
| 05/24/2023 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $120.01 | General |
| Category: SLEEP MEDICINE | ||||||
| 05/18/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $23.80 | General |
| Category: Neurology | ||||||
| 05/09/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $24.32 | General |
| Category: Neurology | ||||||
| 05/02/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $107.29 | General |
| Category: Neurology | ||||||
| 04/27/2023 | IMPEL PHARMACEUTICALS INC. | Trudhesa (Drug) | Food and Beverage | Cash or cash equivalent | $4.67 | General |
| Category: Neurology | ||||||
| 04/11/2023 | Novartis Pharmaceuticals Corporation | MAYZENT (Drug), KESIMPTA | Food and Beverage | In-kind items and services | $17.92 | General |
| Category: Neurology | ||||||
| 01/24/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $33.20 | General |
| Category: Neurology | ||||||
| 09/13/2022 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $13.60 | General |
| 07/28/2022 | Alnylam Pharmaceuticals Inc. | AMVUTTRA (Drug) | Food and Beverage | In-kind items and services | $80.64 | General |
| Category: Genetic Disease | ||||||
| 04/11/2022 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $23.49 | General |
| Category: Neuroscience | ||||||
| 03/14/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $18.42 | General |
| Category: NEUROSCIENCE | ||||||
| 02/28/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.03 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2022 | Allergan, Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: SPASTICITY | ||||||
| 10/18/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $24.26 | General |
| Category: NEUROSCIENCE | ||||||
| 08/05/2021 | SK Life Science, Inc. | — | Food and Beverage | In-kind items and services | $16.08 | General |
| 07/28/2021 | EMD Serono, Inc. | — | Food and Beverage | In-kind items and services | $15.76 | General |
| 05/20/2021 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $124.91 | General |
| Category: Neuroscience | ||||||
| 05/17/2021 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: NEUROSCIENCE | ||||||
| 05/13/2021 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $15.02 | General |
| Category: NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 267 | 386 | $95,049 | $33,484 |
| 2022 | 2 | 288 | 438 | $107,211 | $38,261 |
| 2021 | 5 | 471 | 648 | $164,540 | $64,032 |
| 2020 | 10 | 645 | 773 | $165,458 | $62,432 |
Total Patients
1,671
Total Services
2,245
Medicare Billing
$198,209
Procedure Codes
19
All Medicare Procedures & Services
19 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 226 | 345 | $81,765 | $28,899 | 35.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 41 | 41 | $13,284 | $4,585 | 34.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 247 | 397 | $93,927 | $33,549 | 35.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 41 | 41 | $13,284 | $4,712 | 35.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 308 | 485 | $114,459 | $45,321 | 39.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 94 | 94 | $30,456 | $11,107 | 36.5% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 40 | 40 | $16,240 | $6,267 | 38.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2021 | 18 | 18 | $1,548 | $828.00 | 53.5% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $1,837 | $508.69 | 27.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 279 | 372 | $78,120 | $28,038 | 35.9% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 102 | 102 | $41,004 | $14,583 | 35.6% |
| 95957 | Digital analysis of electrical brain wave activity (eeg) | Facility | 2020 | 64 | 67 | $10,564 | $5,384 | 51.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 27 | 57 | $8,094 | $3,208 | 39.6% |
| 95816 | Measurement and recording of brain wave (eeg) activity, awake and drowsy | Facility | 2020 | 63 | 65 | $5,590 | $2,948 | 52.7% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 38 | 38 | $5,624 | $1,969 | 35.0% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 11 | 11 | $4,884 | $1,917 | 39.3% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 33 | 33 | $4,686 | $1,765 | 37.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 15 | 15 | $4,110 | $1,521 | 37.0% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2020 | 13 | 13 | $2,782 | $1,098 | 39.5% |
About Dr. Timothy Martin, DO
Dr. Timothy Martin, DO is a Neurology healthcare provider based in Lancaster, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1750355822.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Timothy Martin, DO has received a total of $1,502 in payments from pharmaceutical and medical device companies, with $20.33 received in 2024. These payments were reported across 43 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,478).
As a Medicare-enrolled provider, Martin has provided services to 1,671 Medicare beneficiaries, totaling 2,245 services with total Medicare billing of $198,209. Data is available for 4 years (2020–2023), covering 19 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Lancaster, PA
- Active Since 02/15/2006
- Last Updated 12/06/2017
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1750355822
Products in Payments
- Trudhesa (Drug) $160.08
- ZEPOSIA (Drug) $148.40
- Coronary Orbital Atherectomy System (Device) $141.78
- KESIMPTA (Drug) $124.39
- VERCISE (Device) $122.63
- WAKIX (Drug) $120.01
- VYVGART (Drug) $110.00
- AMVUTTRA (Drug) $80.64
- QULIPTA (Drug) $73.25
- BOTOX (Biological) $64.66
- TYSABRI (Biological) $56.82
- MAYZENT (Drug) $41.04
- MAVENCLAD (Drug) $33.20
- VYEPTI (Biological) $24.16
- INBRIJA (Drug) $23.54
- NORTHERA (Drug) $18.42
- OCREVUS (Biological) $18.32
- DUOPA (Drug) $17.57
- AJOVY (Drug) $16.56
- RYTARY (Drug) $16.28
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Neurology Doctors in Lancaster
Dr. Jarod John, M.d, M.D
Neurology — Payments: $28,091
Neurology $28,091
Dr. Jyhgong Hou, Md, MD
Neurology — Payments: $23,179
Neurology $23,179
Gautam Kareti, Md, MD
Neurology — Payments: $21,559
Neurology $21,559
Lingaiah Janumpally, Md, MD
Neurology — Payments: $6,751
Neurology $6,751
Dr. Christie Williamson, Md, MD
Neurology — Payments: $6,617
Neurology $6,617
Dr. Hany Salama, Md, MD
Neurology — Payments: $3,576
Neurology $3,576